Related Experiment Video
Updated: May 18, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Evidence that BRCA1- or BRCA2-associated cancers are not inevitable
Bess Levin1, Denise Lech, Bernard Friedenson
1Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois Chicago, Chicago, Illinois 60607, USA.
BRCA1/2 gene mutations increase cancer risk by impairing DNA repair. However, bromodeoxyuridine (BrdU) overestimates DNA damage, suggesting cancers in carriers may be preventable, not inevitable.
Area of Science:
- Genetics and Genomics
- Cancer Biology
- DNA Repair Mechanisms
Background:
- BRCA1 and BRCA2 gene mutations are linked to hereditary breast and ovarian cancers due to deficiencies in repairing complex DNA damage.
- Genomic instability arising from unrepaired DNA damage is considered a key factor in cancer predisposition.
- Previous research suggested that spontaneous DNA damage and associated cancers in BRCA1/2 mutation carriers might be inevitable.
Purpose of the Study:
- To re-evaluate the role of bromodeoxyuridine (BrdU) in assessing spontaneous DNA damage and sister chromatid exchanges (SCEs).
- To challenge the notion that cancers in BRCA1/2 mutation carriers are unavoidable.
- To remove theoretical limitations hindering the development of chemoprevention strategies for BRCA1/2-associated cancers.
Main Methods:
- Analysis of evidence regarding spontaneous chromosome abnormalities and epidemiological data.
- Critique of methodologies using bromodeoxyuridine (BrdU) for measuring DNA damage and SCEs.
- Reinterpretation of existing data in light of BrdU's mutagenic properties.
Main Results:
- The routine use of bromodeoxyuridine (BrdU) likely leads to an overestimation of spontaneous DNA damage and SCEs.
- BrdU itself acts as a mutagen, confounding previous findings on DNA damage rates.
- Epidemiological data and evidence of spontaneous chromosome abnormalities suggest exogenous mutagens play a significant role, not inevitable cancer development.
Conclusions:
- The inevitability of cancer in all BRCA1/2 mutation carriers is not supported by current evidence.
- The overestimation of DNA damage due to BrdU use has been a significant limitation.
- This study removes a theoretical barrier, paving the way for developing effective chemoprevention strategies to delay or prevent cancers in BRCA1/2 mutation carriers.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
09:24Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Related Concept Videos
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...